Navigation Links
Potential Early Warning System for Lung Cancer Identified

Researchers at The University of Nottingham in the British Midlands

Identify Possible Early Detection for Lung Cancer Patients

CHICAGO, Oct. 25 /PRNewswire/ -- Today the British Midlands Development Corporation announced that new research from The University of Nottingham has pinpointed a potential early warning system for lung cancer.

The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent. Early diagnosis means earlier treatment -- which is much more likely to be effective.

Worldwide, lung cancer kills around 900,000 people every year, and can take 20 years or more to develop fully. But it is usually only picked up at an advanced stage, when the chances of successful treatment are minimal.

As yet, there is no effective early warning system to detect the disease in its early treatable stages, and the dismal long-term prospects of patients with lung cancer have changed little in the past 30 years.

The research team at Nottingham, in collaboration with a team at Johannes Gutenberg University in Germany, analyzed blood (plasma) samples from 50 healthy volunteers and 104 people with different types of lung cancer.

They tested for autoantibodies -- immune system proteins directed at the body's own tissues, in response to specific chemical signals in the body. They looked in particular for a panel of seven autoantibodies, which are associated with 'solid tumors,' such a lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes are taking place.

They found the presence of all seven autoantibodies, and very high levels of at least one of the seven autoantibodies in almost eight out of 10 samples taken from patients with confirmed lung cancer.

And they were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, the body's 'gatekeepers'. This indicates that the disease had not yet spread elsewhere and offers an 80% chance of a cure.

Only one healthy volunteer had more than one of these autoantibodies in their blood.

Other research has indicated that these autoantibodies can be picked up as early as five years before clinical symptoms start to show.

This study is one of a number of studies looking at autoantibodies in cancer.

In a previous study, published earlier this year in the Annals of Oncology, the researchers found abnormally high levels of specific autoantibodies in patients with breast cancer, prompting them to suggest that a test for these could be added to the screening program and may be helpful as an aid to the diagnosis of early breast cancer, especially in individuals at risk of developing the disease such as those with a strong family history. This study also demonstrated that these autoantibodies could be detected before clinical presentation.

Reference: 'Autoantibodies in lung cancer: possibilities for early detection and subsequent care'

Online First Thorax 2007; doi: 10.1136/thx.2007.083592.

Notes to editors: The University of Nottingham is Britain's University of the Year (The Times Higher Awards 2006). It undertakes world-changing research, provides innovative teaching and a student experience of the highest quality. Ranked by Newsweek in the world's Top 75 universities, its academics have won two Nobel Prizes since 2003. The University is an international institution with campuses in the United Kingdom, Malaysia and China.

About The British Midlands Development Corporation

The British Midlands Development Corporation is the North American economic development agency for central England. The Midlands region is located just one hour north of London and includes the major commercial centers of Birmingham, Nottingham, Coventry and Northampton.

As an agency funded by the UK Government, The British Midlands Development Corporation provides specialist advice and support to North American companies seeking to establish a presence or expand a current operation in the region. The British Midlands Development Corporation provides access to business networks, details about sources for grants and funding, business support services, and information to help companies identify opportunities to develop and grow.

The British Midlands Development Corporation is based in Chicago with branch offices in Boston, Washington DC and San Jose.

For more information, please visit our website at

Press Contact

Shirar O'Connor - Mugler

646 496 7668

SOURCE The British Midlands Development Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. New Information on the Potential of Plasmin Shared at ISTH Congress
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
6. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
9. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
10. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
11. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
Post Your Comments:
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... Wound Care Market by Type (Dressings, Therapy Devices, Active ... Facility, Out-Patient Facility), and Geography - Global Forecast to ... --> --> The purpose of ... forecast of the global advanced wound care market. It ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special ... 10% off of their purchase of lice treatment product. In addition, customers will receive ... a company spokesperson. “Finding lice is a sure way to ruin the holidays, so ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... motto of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... conference will begin on Sunday, March 6, 2016, at Caesars Palace in Las ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... San Francisco, California (PRWEB) , ... November 27, 2015 , ... ... 1969 Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of ... 1969 at the Canterbury House at the University of Michigan in Ann Arbor. The ...
Breaking Medicine News(10 mins):